IL6 and Cachexia: Thirteen days after inoculation with tumor cells, CHX207 mice exhibited key clinical features of cancer cachexia, including systemic inflammation, increased plasma IL-6 concentrations, increased energy expenditure, adipose tissue loss, skeletal muscle wasting, and weight loss.39